APA (7th ed.) Citation

Karim, N. A., Ullah, A., Pathrose, P., Fathallah, H., Perry, A., Morris, J. C., . . . Starnes, S. L. (2022). Does Molecular Profiling of KRAS -Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning? Current Oncology, 29(7), 4779. https://doi.org/10.3390/curroncol29070379

Chicago Style (17th ed.) Citation

Karim, Nagla Abdel, Asad Ullah, Peterson Pathrose, Hassana Fathallah, Ashley Perry, John C. Morris, Jiang Wang, and Sandra L. Starnes. "Does Molecular Profiling of KRAS -Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?" Current Oncology 29, no. 7 (2022): 4779. https://doi.org/10.3390/curroncol29070379.

MLA (9th ed.) Citation

Karim, Nagla Abdel, et al. "Does Molecular Profiling of KRAS -Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?" Current Oncology, vol. 29, no. 7, 2022, p. 4779, https://doi.org/10.3390/curroncol29070379.